Quinolones are currently the most commonly used group of antimicrobial agents in Norwegian aquaculture. The aims of this study were to examine and compare the pharmacokinetic properties of the quinolones oxolinic acid, flumequine, sarafloxacin, and enrofloxacin after intravascular and oral administration to Atlantic salmon (Salmo salar) by using identical experimental designs. The study was performed in seawater at 10.2 ؎ 0.2؇C with Atlantic salmon weighing 240 ؎ 50 g (mean ؎ standard deviation). The bioavailability varied considerably among the four quinolones. Following oral administration of medicated feed, the bioavailabilities of oxolinic acid, flumequine, sarafloxacin, and enrofloxacin were 30.1, 44.7, 2.2, and 55.5%, respectively. Taking the different dosages (25 mg/kg of body weight for oxolinic acid and flumequine and 10 mg/kg for sarafloxacin and enrofloxacin) into account, enrofloxacin showed the highest maximum concentration in plasma, followed by flumequine, oxolinic acid, and sarafloxacin. Following intravenous administration, the volumes of distribution at steady state of oxolinic acid, flumequine, sarafloxacin, and enrofloxacin were 5.4, 3.5, 2.3, and 6.1 liters/kg, respectively. Hence, all the quinolones showed good tissue penetration in Atlantic salmon. The elimination half-life of three of the quinolones, oxolinic acid, flumequine, and sarafloxacin, was less than or equal to 24 h, with oxolinic acid showing the shortest (18.2 h). On the other hand, the elimination half-life of enrofloxacin was estimated to be 34.2 h, almost twice that of oxolinic acid. This study showed that flumequine and enrofloxacin had better pharmacokinetic properties, compared with those of oxolinic acid, in Atlantic salmon held in seawater.In recent years, the quinolones oxolinic acid and flumequine have been the most frequently used antimicrobial agents in Norwegian aquaculture (17). Sarafloxacin, enrofloxacin, and other fluoroquinolones have showed enhanced in vitro activities compared with those of older quinolones, such as oxolinic acid and flumequine, against fish pathogenic bacteria (2, 21). Studies have also revealed better bactericidal activity (3, 16), as well as promising clinical efficacy in treatment of bacterial fish diseases (6,14,29). The chemical structures of oxolinic acid, flumequine, sarafloxacin, and enrofloxacin are shown in Fig. 1.The pharmacokinetic properties of quinolones have not been extensively studied in fish. However, there are several single reports indicating that their pharmacokinetic properties vary considerably from one compound to another (7,11,19,24). It is therefore important to clarify the pharmacokinetic properties of the different quinolones in fish, so as to be able to select the most beneficial compound for the treatment of bacterial fish diseases.Some data concerning the pharmacokinetic properties of oxolinic acid and flumequine in Atlantic salmon (Salmo salar) are available (11,12,24). As regards sarafloxacin and enrofloxacin in Atlantic salmon, one paper on the kinetics of s...